Literature DB >> 27863311

Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.

Maike Engel1, Tania M Lincoln2.   

Abstract

This study examined the validity of using a self-rating scale for assessing the motivation and pleasure domain of negative symptoms in the general population by examining the concordance of self- and observer-rated negative symptoms in a healthy sample and by comparing it with a patient sample. The motivation and pleasure domain of negative symptoms was assessed using the observer-rated Clinical Assessment Interview for Negative Symptoms (CAINS) and the self-rated Motivation and Pleasure Scale-Self-Report (MAP-SR). We found 52.9% of the healthy individuals and 46% of the patients to have relatively equal self- and observer-ratings. Despite the absence of extreme discrepancies, 31.4% of the healthy individuals and 14% of the patients rated their negative symptoms as more severe, whereas 15.7% of the healthy individuals and 40% of the patients rated them as less severe than the observers. By using self-ratings in combination with observer-ratings, possible discrepancies can be uncovered, which may be relevant for the successful treatment of negative symptoms.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Assessment; Concordance; Negative symptoms; Schizophrenia; Self-rating

Mesh:

Year:  2016        PMID: 27863311     DOI: 10.1016/j.psychres.2016.11.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study.

Authors:  Siv Hege Lyngstad; Erlend Strand Gardsjord; Magnus Johan Engen; Beathe Haatveit; Henrik Myhre Ihler; Kirsten Wedervang-Resell; Carmen Simonsen; Ingrid Melle; Ann Færden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-04       Impact factor: 5.270

2.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

3.  Metacognition moderates the relationship between self-reported and clinician-rated motivation in schizophrenia.

Authors:  Lauren Luther; Kelsey A Bonfils; Melanie W Fischer; Annalee V Johnson-Kwochka; Michelle P Salyers
Journal:  Schizophr Res Cogn       Date:  2019-04-17

4.  Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis.

Authors:  Karlijn S F M Hermans; Inez Myin-Germeys; Charlotte Gayer-Anderson; Matthew J Kempton; Lucia Valmaggia; Philip McGuire; Robin M Murray; Philippa Garety; Til Wykes; Craig Morgan; Zuzana Kasanova; Ulrich Reininghaus
Journal:  Psychol Med       Date:  2020-05-22       Impact factor: 7.723

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.